Chargement en cours...
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
BACKGROUND: The use of oral ribavirin (RBV) for respiratory syncytial virus (RSV) infections is not well studied. With the drastic increase in the cost of aerosolized RBV, we aimed to compare outcomes of hematopoietic cell transplant (HCT) recipients treated with oral or aerosolized RBV for RSV infe...
Enregistré dans:
| Publié dans: | Clin Infect Dis |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7108094/ https://ncbi.nlm.nih.gov/pubmed/30202920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy760 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|